In vitro experiments demonstrated that pioglitazone inhibits invasiveness of these cells (Figure S1), and promotes a more differentiated phenotype in 3-dimensional Matrigel cultures (Figure S1), consistent with what we have observed with PPARγ activation in human NSCLC [10]. This evidence concerns the gene PPARG and non-small cell lung carcinoma.